rs57969630

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_000183.3(HADHB):​c.830A>G​(p.Lys277Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00149 in 1,609,410 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0063 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00099 ( 10 hom. )

Consequence

HADHB
NM_000183.3 missense

Scores

1
4
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 7.10

Publications

5 publications found
Variant links:
Genes affected
HADHB (HGNC:4803): (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta) This gene encodes the beta subunit of the mitochondrial trifunctional protein, which catalyzes the last three steps of mitochondrial beta-oxidation of long chain fatty acids. The mitochondrial membrane-bound heterocomplex is composed of four alpha and four beta subunits, with the beta subunit catalyzing the 3-ketoacyl-CoA thiolase activity. The encoded protein can also bind RNA and decreases the stability of some mRNAs. The genes of the alpha and beta subunits of the mitochondrial trifunctional protein are located adjacent to each other in the human genome in a head-to-head orientation. Mutations in this gene result in trifunctional protein deficiency. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2013]
HADHB Gene-Disease associations (from GenCC):
  • mitochondrial trifunctional protein deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 25 curated pathogenic missense variants (we use a threshold of 10). The gene has 2 curated benign missense variants. Gene score misZ: 0.64924 (below the threshold of 3.09). Trascript score misZ: 0.82597 (below the threshold of 3.09). GenCC associations: The gene is linked to mitochondrial trifunctional protein deficiency.
BP4
Computational evidence support a benign effect (MetaRNN=0.012434572).
BP6
Variant 2-26280012-A-G is Benign according to our data. Variant chr2-26280012-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 203750.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00628 (957/152320) while in subpopulation AFR AF = 0.0215 (894/41582). AF 95% confidence interval is 0.0203. There are 7 homozygotes in GnomAd4. There are 445 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HADHBNM_000183.3 linkc.830A>G p.Lys277Arg missense_variant Exon 10 of 16 ENST00000317799.10 NP_000174.1
HADHBNM_001281512.2 linkc.785A>G p.Lys262Arg missense_variant Exon 9 of 15 NP_001268441.1
HADHBNM_001281513.2 linkc.764A>G p.Lys255Arg missense_variant Exon 11 of 17 NP_001268442.1
HADHBXM_011532803.2 linkc.830A>G p.Lys277Arg missense_variant Exon 10 of 16 XP_011531105.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HADHBENST00000317799.10 linkc.830A>G p.Lys277Arg missense_variant Exon 10 of 16 1 NM_000183.3 ENSP00000325136.5

Frequencies

GnomAD3 genomes
AF:
0.00624
AC:
950
AN:
152202
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0214
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00600
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00573
GnomAD2 exomes
AF:
0.00240
AC:
604
AN:
251352
AF XY:
0.00225
show subpopulations
Gnomad AFR exome
AF:
0.0213
Gnomad AMR exome
AF:
0.000983
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.000815
GnomAD4 exome
AF:
0.000991
AC:
1444
AN:
1457090
Hom.:
10
Cov.:
29
AF XY:
0.00112
AC XY:
811
AN XY:
725124
show subpopulations
African (AFR)
AF:
0.0198
AC:
661
AN:
33328
American (AMR)
AF:
0.00110
AC:
49
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26108
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39670
South Asian (SAS)
AF:
0.00673
AC:
579
AN:
86080
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.000227
AC:
1
AN:
4408
European-Non Finnish (NFE)
AF:
0.0000144
AC:
16
AN:
1109236
Other (OTH)
AF:
0.00228
AC:
137
AN:
60124
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.435
Heterozygous variant carriers
0
70
140
211
281
351
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00628
AC:
957
AN:
152320
Hom.:
7
Cov.:
32
AF XY:
0.00597
AC XY:
445
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0215
AC:
894
AN:
41582
American (AMR)
AF:
0.00144
AC:
22
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00580
AC:
28
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68022
Other (OTH)
AF:
0.00567
AC:
12
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
46
92
138
184
230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00265
Hom.:
10
Bravo
AF:
0.00697
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0195
AC:
86
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00276
AC:
335
Asia WGS
AF:
0.00924
AC:
35
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Mitochondrial trifunctional protein deficiency Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Feb 02, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mitochondrial trifunctional protein deficiency 2 Benign:1
Nov 22, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.30
T;T;T;.
Eigen
Benign
-0.056
Eigen_PC
Benign
0.16
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.92
D;D;D;D
MetaRNN
Benign
0.012
T;T;T;T
MetaSVM
Uncertain
-0.021
T
MutationAssessor
Benign
0.27
.;N;.;.
PhyloP100
7.1
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.2
N;N;N;N
REVEL
Uncertain
0.34
Sift
Benign
0.32
T;T;T;T
Sift4G
Benign
0.37
T;T;T;T
Polyphen
0.0010
B;B;B;.
Vest4
0.16
MVP
0.89
MPC
0.11
ClinPred
0.032
T
GERP RS
5.4
Varity_R
0.30
gMVP
0.51
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs57969630; hg19: chr2-26502880; API